|
Price $12.00
10 Tablets per Strip
Wt. 50gm
|
|
Serlift (25mg)
|
What is
Serlift (25mg)
?
SERLIFT is used for Treatment of major depressive disorder including accompanying symptoms of anxiety.
It is also indicated in preventing relapse of the initial episode of depression or recurrence of further episodes including accompanying symptoms of anxiety.
Treatment of obsessions and compulsions in patients with obsessive compulsive disorder (OCD)
Treatment of panic disorder with or without agoraphobia.
Storage
SERLIFT tablet should be stored at controlled room temperature between 15° to 30 C°.
Dosage
Adult Depression Initially 50 mg as a single daily dose. May be increased after several wks w/ increments of 50 mg at intervals of at least 1 wk, to max 200 mg once daily. Elderly Initially 12.5-25 mg once daily. OCD 50 mg once daily. May be increased at intervals of at least 1 wk, up to 200 mg. Panic disorder Initially, 25 mg once daily. After 1 wk, may be increased to 50 mg once daily. Further increments may be made up to 200 mg/day. Dose =150 mg should not be used for >5 wk.
..
Side Effects
SSRIs are considered less sedating and have fewer antimuscarinic and cardiotoxic effects than tricyclic antidepressants. However the following are the reported side effects: Increased sweating, dry mouth, insomnia, nausea, dyspepsia, tremor , dizziness. Also diarrhoea, vomiting, abdominal cramps, anxiety, nervousness and blurred vision.
Hypersensitivity reactions including rash, erythema multiforme, photosensitivity, angioedema, arthralgia and myalgia are also reported. Delayed ejaculation, weight loss and abnormal platelet function were also reported.
Precautions
Close supervision of high risk patient (with suicide attempt) should accompany initial drug therapy.
Sertraline should be used with caution in patients with hepatic impairment. In liver cirrhosis a lower dose or a lower frequency dosing should be employed. Caution is required in patients with severe renal impairment, although renal route is a minor route of elimination.
Sertraline should be introduced with care in patients with seizure disorders.
Women of childbearing potential should employ an adequate method of contraception if taking sertraline.
Concomitant use of alcohol with sertraline should avoided. Although adverse reactions with lithium have not been reported it is recommended that plasma lithium levels be monitored following initiation of sertraline therapy with appropriate adjustments of lithium dose.
Tricyclic antidepressants, propafenone or flecainide may require lower doses if given concurrently with sertraline.
|
|
|